Seeing Is Believing
Currently out of the existing stock ratings of Graig Suvannavejh, 110 are a BUY (67.48%), 47 are a HOLD (28.83%), 6 are a SELL (3.68%).
Analyst Graig Suvannavejh works at MIZUHO with a stock forecast success ratio of 57.49% fulfilled within 89.06 days on average.
Graig Suvannavejh’s has documented 339 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ADVM, Adverum Biotechnologies at 29-Apr-2024.
Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for ADVM (ADVERUM BIOTECHNOLOGIES) at 4/28/2020. The price target of $17 was fulfilled within 7 days with a profit of $4.84 (39.8%) receiving and performance score of 56.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
15
$9.66 (180.90%)
8
4 months 19 days ago
1/4 (25%)
$7 (87.50%)
128
Buy
9
$3.66 (68.54%)
10
5 months 16 days ago
1/5 (20%)
$4.69 (108.82%)
24
Sell
4
$-1.34 (-25.09%)
9
7 months 8 days ago
2/2 (100%)
$-2.98 (-42.69%)
36
Hold
10
$4.66 (87.27%)
10
8 months 26 days ago
1/5 (20%)
$2.64 (35.87%)
332
Buy
41
$35.66 (667.79%)
41
8 months 29 days ago
0/4 (0%)
$32.23 (367.50%)
Which stock is Graig Suvannavejh is most bullish on?
Which stock is Graig Suvannavejh is most reserved on?
What Year was the first public recommendation made by Graig Suvannavejh?